SCHEMBL1855243

SCHEMBL1855243

O=C(O)C(=O)N(Cc1ccccc1-c1ccccc1)Cc1c(Br)cc(C(=O)NCCc2ccc(Oc3ccccc3)cc2)cc1Br

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
POLB P06746 1/20 0.41
PLAAT3 P53816 2/20 0.40
PLAAT5 Q96KN8 2/20 0.40
PLAAT2 Q9NWW9 2/20 0.40
PLAAT4 Q9UL19 2/20 0.40
KLK7 P49862 1/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
EPHX2 P34913 3/20 0.38
LTA4H P09960 2/20 0.38
PTGDR2 Q9Y5Y4 2/20 0.38
RXFP1 Q9HBX9 1/20 0.37
PARP1 P09874 1/20 0.37
MAPT P10636 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
MMP1 P03956 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4315038 0.92 MEN1 (0.44) MEN1KMT2AKLK7NPC1RAB9A
SCHEMBL1857107 0.89 MEN1 (0.44) MEN1KMT2APOLBPLAAT3PLAAT5
SCHEMBL4325815 0.86 NPC1 (0.45) MEN1KMT2APOLBPLAAT3PLAAT5
SCHEMBL4320069 0.85 PTGES (0.45) MEN1KMT2APOLBPLAAT3PLAAT5
SCHEMBL7158692 0.83 MEN1 (0.43) MEN1KMT2APOLBPLAAT3PLAAT5
SCHEMBL1868356 0.83 MEN1 (0.47) MEN1KMT2AKLK7NPC1RAB9A
SCHEMBL1852654 0.83 LTA4H (0.45) MEN1KMT2APOLBPLAAT3PLAAT5
SCHEMBL1857111 0.82 MEN1 (0.45) MEN1KMT2APOLBPLAAT3PLAAT5
SCHEMBL1856112 0.82 MEN1 (0.46) MEN1KMT2APOLBPLAAT3PLAAT5
SCHEMBL1852719 0.82 ESRRG (0.43) MEN1KMT2APOLBPLAAT3PLAAT5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732534-B1 USE OF METHYLENE AMIDE DERIVATIVES IN CARDIOVASCULAR DISORDERS SERONO LAB (CH) 2008-07-23 EP claimed
US-20070185118-A1 Use of methylene amide derivatives in cardiovascular disorders APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-09 US claimed
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) APPLIED RESEARCH SYSTEMS ARS (NL) 2005-06-09 US claimed
EP-1470102-B1 SUBSTITUTED METHYLENE AMIDE DERIVATIVES AS MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) MERCK SERONO SA (CH) 2011-05-25 EP disclosed
US-7592477-B2 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (PTPs) LABORATOIRES SERONO SA (CH) 2009-09-22 US disclosed
EP-1732534-B1 USE OF METHYLENE AMIDE DERIVATIVES IN CARDIOVASCULAR DISORDERS SERONO LAB (CH) 2008-07-23 EP disclosed
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) APPLIED RESEARCH SYSTEMS ARS (NL) 2005-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185118-A1 Use of methylene amide derivatives in cardiovascular disorders TNNI3, TNNT2, ADM2 MEN1 3574/4885KMT2A 1555/4885POLB 2855/4885
US-20050124656-A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) PTPRS, PTPA, PTPMT1 MEN1 2496/4885KMT2A 740/4885POLB 4742/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.